361 related articles for article (PubMed ID: 21717513)
1. Triptolide down-regulates COX-2 expression and PGE2 release by suppressing the activity of NF-κB and MAP kinases in lipopolysaccharide-treated PC12 cells.
Geng Y; Fang M; Wang J; Yu H; Hu Z; Yew DT; Chen W
Phytother Res; 2012 Mar; 26(3):337-43. PubMed ID: 21717513
[TBL] [Abstract][Full Text] [Related]
2. Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells: role of ERK1/2, p38 MAPK, and NF-kappaB.
Lin CC; Lin WN; Wang WJ; Sun CC; Tung WH; Wang HH; Yang CM
Cardiovasc Res; 2009 Jun; 82(3):522-31. PubMed ID: 19233864
[TBL] [Abstract][Full Text] [Related]
3. Triptolide inhibits murine-inducible nitric oxide synthase expression by down-regulating lipopolysaccharide-induced activity of nuclear factor-kappa B and c-Jun NH2-terminal kinase.
Kim YH; Lee SH; Lee JY; Choi SW; Park JW; Kwon TK
Eur J Pharmacol; 2004 Jun; 494(1):1-9. PubMed ID: 15194445
[TBL] [Abstract][Full Text] [Related]
4. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
[TBL] [Abstract][Full Text] [Related]
5. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088
[TBL] [Abstract][Full Text] [Related]
6. [Enhancement by FK506 of triptolide-induced inhibition of expression of COX-2 and iNOS in human rheumatoid arthritis synovial fibroblasts].
Yao HP; Shao XT; Sun WJ; Shao CS; Zhang LH
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):277-82. PubMed ID: 12621554
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.
Jang SI; Kim HJ; Kim YJ; Jeong SI; You YO
Eur J Pharmacol; 2006 Aug; 542(1-3):1-7. PubMed ID: 16797002
[TBL] [Abstract][Full Text] [Related]
8. Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production.
Tao X; Schulze-Koops H; Ma L; Cai J; Mao Y; Lipsky PE
Arthritis Rheum; 1998 Jan; 41(1):130-8. PubMed ID: 9433878
[TBL] [Abstract][Full Text] [Related]
9. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways.
Liu Q; Chen T; Chen G; Shu X; Sun A; Ma P; Lu L; Cao X
Mol Immunol; 2007 Apr; 44(10):2686-96. PubMed ID: 17223196
[TBL] [Abstract][Full Text] [Related]
10. Triptolide inhibits COX-2 expression and PGE2 release by suppressing the activity of NF-kappaB and JNK in LPS-treated microglia.
Gong Y; Xue B; Jiao J; Jing L; Wang X
J Neurochem; 2008 Nov; 107(3):779-88. PubMed ID: 18761708
[TBL] [Abstract][Full Text] [Related]
11. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells.
Jang BC; Lim KJ; Choi IH; Suh MH; Park JG; Mun KC; Bae JH; Shin DH; Suh SI
Int J Mol Med; 2007 May; 19(5):757-63. PubMed ID: 17390080
[TBL] [Abstract][Full Text] [Related]
12. Triptolide inhibits COX-2 expression via NF-kappa B pathway in astrocytes.
Dai YQ; Jin DZ; Zhu XZ; Lei DL
Neurosci Res; 2006 Jun; 55(2):154-60. PubMed ID: 16600409
[TBL] [Abstract][Full Text] [Related]
13. Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappaB pathways.
Chang YC; Li PC; Chen BC; Chang MS; Wang JL; Chiu WT; Lin CH
Cell Signal; 2006 Aug; 18(8):1235-43. PubMed ID: 16289764
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory activity of bark of Dioscorea batatas DECNE through the inhibition of iNOS and COX-2 expressions in RAW264.7 cells via NF-κB and ERK1/2 inactivation.
Jin M; Suh SJ; Yang JH; Lu Y; Kim SJ; Kwon S; Jo TH; Kim JW; Park YI; Ahn GW; Lee CK; Kim CH; Son JK; Son KH; Chang HW
Food Chem Toxicol; 2010 Nov; 48(11):3073-9. PubMed ID: 20691245
[TBL] [Abstract][Full Text] [Related]
15. Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells.
Oh JH; Lee TJ; Park JW; Kwon TK
Eur J Pharmacol; 2008 Dec; 599(1-3):11-7. PubMed ID: 18838070
[TBL] [Abstract][Full Text] [Related]
16. Linoleic acid-induced expression of inducible nitric oxide synthase and cyclooxygenase II via p42/44 mitogen-activated protein kinase and nuclear factor-kappaB pathway in retinal pigment epithelial cells.
Fang IM; Yang CH; Yang CM; Chen MS
Exp Eye Res; 2007 Nov; 85(5):667-77. PubMed ID: 17825288
[TBL] [Abstract][Full Text] [Related]
17. EV71 induces COX-2 expression via c-Src/PDGFR/PI3K/Akt/p42/p44 MAPK/AP-1 and NF-kappaB in rat brain astrocytes.
Tung WH; Lee IT; Hsieh HL; Yang CM
J Cell Physiol; 2010 Aug; 224(2):376-86. PubMed ID: 20333648
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation.
Zhou HY; Shin EM; Guo LY; Youn UJ; Bae K; Kang SS; Zou LB; Kim YS
Eur J Pharmacol; 2008 May; 586(1-3):340-9. PubMed ID: 18378223
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional down-regulation of thromboxane A(2) receptor expression via activation of MAPK ERK1/2, p38/NF-kappaB pathways.
Zhang W; Zhang Y; Edvinsson L; Xu CB
J Vasc Res; 2009; 46(2):162-74. PubMed ID: 18769070
[TBL] [Abstract][Full Text] [Related]
20. PGE(2) induces MUC2 and MUC5AC expression in human intrahepatic biliary epithelial cells via EP4/p38MAPK activation.
Yang L; Junmin S; Hong Y; Shuodong W
Ann Hepatol; 2013; 12(3):479-86. PubMed ID: 23619266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
